QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, August 22, 2007, 27(34):9115-9129; doi:10.1523/JNEUROSCI.2361-07.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Asuni, A. A. Articles by Sigurdsson, E. M. Search for Related Content PubMed PubMed Citation Articles by Asuni, A. A. Articles by Sigurdsson, E. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-PROLINE Medline Plus Health Information Dementia

 Previous Article  |  Next Article 

Neurobiology of Disease
Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements

Ayodeji A. Asuni,¹ Allal Boutajangout,¹ David Quartermain,² and Einar M. Sigurdsson^1,3

Departments of ¹Psychiatry, ²Neurology, and ³Pathology, New York University School of Medicine, New York, New York 10016

Correspondence should be addressed to Dr. Einar M. Sigurdsson, Departments of Psychiatry and Pathology, Millhauser Laboratories, HN 418, New York University School of Medicine, 560 First Avenue, New York, NY 10016. Email: einar.sigurdsson{at}med.nyu.edu

Immunotherapies for various neurodegenerative diseases have recently emerged as a promising approach for clearing pathological protein conformers in these disorders. This type of treatment has not been assessed in models that develop neuronal tau aggregates as observed in frontotemporal dementia and Alzheimer's disease. Here, we present that active immunization with a phosphorylated tau epitope, in P301L tangle model mice, reduces aggregated tau in the brain and slows progression of the tangle-related behavioral phenotype. Females had more tau pathology than males but were also more receptive to the immunotherapy. The tau antibodies generated in these animals recognized pathological tau on brain sections. Performance on behavioral assays that require extensive motor coordination correlated with tau pathology in corresponding brain areas, and antibody levels against the immunogen correlated inversely with tau pathology. Interestingly, age-dependent autoantibodies that recognized recombinant tau protein but not the immunogen were detected in the P301L mice. To confirm that anti-tau antibodies could enter the brain and bind to pathological tau, FITC-tagged antibodies purified from a P301L mouse, with a high antibody titer against the immunogen, were injected into the carotid artery of P301L mice. These antibodies were subsequently detected within the brain and colocalized with PHF1 and MC1 antibodies that recognize pathological tau. Currently, no treatment is available for clearing tau aggregates. Our present findings may lead to a novel therapy targeting one of the major hallmarks of Alzheimer's disease and frontotemporal dementia.

Key words: tau; P301L; tangles; transgenic mice; immunization; behavior

---

Received Nov. 27, 2006; accepted June 21, 2007.

Correspondence should be addressed to Dr. Einar M. Sigurdsson, Departments of Psychiatry and Pathology, Millhauser Laboratories, HN 418, New York University School of Medicine, 560 First Avenue, New York, NY 10016. Email: einar.sigurdsson{at}med.nyu.edu

This article has been cited by other articles:

				B. Frost, R. L. Jacks, and M. I. Diamond Propagation of Tau Misfolding from the Outside to the Inside of a Cell J. Biol. Chem., May 8, 2009; 284(19): 12845 - 12852. [Abstract] [Full Text] [PDF]

				R. P. Friedland, J. M. Tedesco, A. C. Wilson, C. S. Atwood, M. A. Smith, G. Perry, and M. G. Zagorski Antibodies to Potato Virus Y Bind the Amyloid {beta} Peptide: IMMUNOHISTOCHEMICAL AND NMR STUDIES J. Biol. Chem., August 15, 2008; 283(33): 22550 - 22556. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help